AtaiBeckley (ATAI) Goodwill (2024 - 2026)
AtaiBeckley (ATAI) recorded quarterly Goodwill of $331000.0 in Q1 2026, little changed quarter-over-quarter from $331000.0 in Q4 2025.
AtaiBeckley (ATAI) Goodwill (2024 - 2026) Analysis & Trends
AtaiBeckley has disclosed Goodwill across 2 years of filings, most recently posting $331000.0 for Q3 2025.
- In Q1 2026, Goodwill changed N/A year-over-year to $331000.0; the TTM figure through Mar 2026 stood at $331000.0 (changed N/A YoY), while the FY2025 annual figure was $331000.0, up 10.33% from the prior year.
- Goodwill was $331000.0 for Q1 2026 at AtaiBeckley, roughly flat from $331000.0 in the prior quarter.
- In the past five years, Goodwill ranged from a high of $331000.0 in Q4 2025 to a low of $300000.0 in Q4 2024.
- Historically, Goodwill has averaged $320666.7 across 3 years, with a median of $331000.0 in 2025.
- Biggest YoY gain for Goodwill was 10.33% in 2025; the steepest drop was 10.33% in 2025.
- A 3-year view of Goodwill shows it stood at $300000.0 in 2024, then rose by 10.33% to $331000.0 in 2025, then changed by 0.0% to $331000.0 in 2026.
- The last three Goodwill figures came in at $331000.0 (Q1 2026), $331000.0 (Q4 2025), and $300000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 331,000.00 |
| Dec 31, 2025 | 331,000.00 |
| Sep 30, 2025 | 331,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 331,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Dec 31, 2024 | 300,000.00 |